ArticlePharmaceuticals (Basel, Switzerland)2021

Modulation of the Immune Response by Deferasirox in Myelodysplastic Syndrome Patients.

Hana Votavova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.